• Selvaraj, Senthil, Shachi Patel, Andrew J. Sauer, Robert W. McGarrah, Philip Jones, Lydia Coulter Kwee, Sheryl L. Windsor, et al. “Metabolic Effects of the SGLT2 Inhibitor Dapagliflozin in Heart Failure Across the Spectrum of Ejection Fraction.” Circ Heart Fail 17, no. 11 (November 2024): e011980. https://doi.org/10.1161/CIRCHEARTFAILURE.124.011980.
  • Regan, Jessica A., Robert J. Mentz, Maggie Nguyen, Jennifer B. Green, Lauren K. Truby, Olga Ilkayeva, Christopher B. Newgard, et al. “Mitochondrial metabolites predict adverse cardiovascular events in individuals with diabetes.” JCI Insight 8, no. 17 (September 8, 2023). https://doi.org/10.1172/jci.insight.168563.
  • Wegermann, Kara, Marat Fudim, Ricardo Henao, Catherine F. Howe, Robert McGarrah, Cynthia Guy, Manal F. Abdelmalek, Anna Mae Diehl, and Cynthia A. Moylan. “Serum Metabolites Are Associated With HFpEF in Biopsy-Proven Nonalcoholic Fatty Liver Disease.” J Am Heart Assoc 12, no. 14 (July 18, 2023): e029873. https://doi.org/10.1161/JAHA.123.029873.
  • McGarrah, Robert W., and Phillip J. White. “Branched-chain amino acids in cardiovascular disease.” Nat Rev Cardiol 20, no. 2 (February 2023): 77–89. https://doi.org/10.1038/s41569-022-00760-3.
  • Otvos, James D., Irina Shalaurova, Heidi T. May, Joseph B. Muhlestein, John T. Wilkins, Robert W. McGarrah, and William E. Kraus. “Multimarkers of metabolic malnutrition and inflammation and their association with mortality risk in cardiac catheterisation patients: a prospective, longitudinal, observational, cohort study.” Lancet Healthy Longev 4, no. 2 (February 2023): e72–82. https://doi.org/10.1016/S2666-7568(23)00001-6.
  • McGarrah, Robert W., Maros Ferencik, Stephanie N. Giamberardino, Udo Hoffmann, Borek Foldyna, Julia Karady, Geoffrey S. Ginsburg, William E. Kraus, Pamela S. Douglas, and Svati H. Shah. “Lipoprotein Subclasses Associated With High-Risk Coronary Atherosclerotic Plaque: Insights From the PROMISE Clinical Trial.” J Am Heart Assoc 12, no. 1 (January 3, 2023): e026662. https://doi.org/10.1161/JAHA.122.026662.
  • Shah, Nishant P., Courtney Page, Cynthia L. Green, Michael Gao, Joanna Cavalier, Robert W. McGarrah, Tracy A. DeWald, Devdutta Sangvai, Manesh R. Patel, and Neha J. Pagidipati. “Bending the Cardiovascular Event Curve by Evaluating the Potential Impact of Achieving Low-Density Lipoprotein Cholesterol Goal Across a Large Health System Among Secondary Prevention Patients.” Am J Cardiol 186 (January 1, 2023): 91–99. https://doi.org/10.1016/j.amjcard.2022.10.033.
  • Karády, Julia, Maros Ferencik, Thomas Mayrhofer, Nandini M. Meyersohn, Daniel O. Bittner, Pedro V. Staziaki, Balint Szilveszter, et al. “Risk factors for cardiovascular disease among individuals with hepatic steatosis.” Hepatol Commun 6, no. 12 (December 2022): 3406–20. https://doi.org/10.1002/hep4.2090.
  • Grant, Jelani K., Sarah Snow, Michelle Kelsey, Jennifer Rymer, Anna E. Schaffer, Manesh R. Patel, Robert W. McGarrah, Neha J. Pagidipati, and Nishant P. Shah. “Lipid-Lowering Therapy in Women of Childbearing Age: a Review and Stepwise Clinical Approach.” Curr Cardiol Rep 24, no. 10 (October 2022): 1373–85. https://doi.org/10.1007/s11886-022-01751-z.
  • Yengo, Loïc, Sailaja Vedantam, Eirini Marouli, Julia Sidorenko, Eric Bartell, Saori Sakaue, Marielisa Graff, et al. “A saturated map of common genetic variants associated with human height.” Nature 610, no. 7933 (October 2022): 704–12. https://doi.org/10.1038/s41586-022-05275-y.
  • O’Toole, Thomas, Michelle D. Kelsey, Nishant P. Shah, Robert W. McGarrah, and Neha J. Pagidipati. “Eradicating Atherosclerosis: Should We Start Statins at Younger Ages and at Lower LDL-Cs.” Curr Cardiol Rep 24, no. 10 (October 2022): 1397–1406. https://doi.org/10.1007/s11886-022-01760-y.
  • Grenier-Larouche, Thomas, Lydia Coulter Kwee, Yann Deleye, Paola Leon-Mimila, Jacquelyn M. Walejko, Robert W. McGarrah, Simon Marceau, et al. “Altered branched-chain α-keto acid metabolism is a feature of NAFLD in individuals with severe obesity.” JCI Insight 7, no. 15 (August 8, 2022). https://doi.org/10.1172/jci.insight.159204.
  • Lerman, Joseph B., Stephanie N. Giamberardino, Adrian F. Hernandez, G Michael Felker, Svati H. Shah, and Robert W. McGarrah. “Plasma metabolites associated with functional and clinical outcomes in heart failure with reduced ejection fraction with and without type 2 diabetes.” Sci Rep 12, no. 1 (June 2, 2022): 9183. https://doi.org/10.1038/s41598-022-12973-0.
  • Salah, Husam M., Ambarish Pandey, Harriette G. C. Van Spall, Erin D. Michos, Robert W. McGarrah, and Marat Fudim. “Meta-Analysis of Nonalcoholic Fatty Liver Disease and Incident Heart Failure.” Am J Cardiol 171 (May 15, 2022): 180–81. https://doi.org/10.1016/j.amjcard.2022.02.012.
  • Abdi, Khadar, Ramona Rodriguiz, William Wetsel, Michelle Arlotto, Robert McGarrah, and Phillip White. “Nervous system reduction in branched-chain amino acid metabolism disrupts hippocampal neurogenesis and memory.” BioRxiv, 2022. https://doi.org/10.1101/2022.06.10.495711.
  • Truskey, George, Ellery Jones, Svati Shah, and Robert McGarrah. “ASSESSING THE ROLE OF BRANCHED CHAIN AMINO ACIDS IN ATHEROSCLEROSIS USING A HUMAN VASCULAR MICROPHYSIOLOGICAL SYSTEM.” In TISSUE ENGINEERING PART A, 28:S570–S570, 2022.
  • Fudim, Marat, Lin Zhong, Kershaw V. Patel, Rohan Khera, Manal F. Abdelmalek, Anna Mae Diehl, Robert W. McGarrah, et al. “Nonalcoholic Fatty Liver Disease and Risk of Heart Failure Among Medicare Beneficiaries.” J Am Heart Assoc 10, no. 22 (November 16, 2021): e021654. https://doi.org/10.1161/JAHA.121.021654.
  • Salah, Husam M., Ambarish Pandey, Anzhela Soloveva, Manal F. Abdelmalek, Anna Mae Diehl, Cynthia A. Moylan, Kara Wegermann, et al. “Relationship of Nonalcoholic Fatty Liver Disease and Heart Failure With Preserved Ejection Fraction.” JACC Basic Transl Sci 6, no. 11 (November 2021): 918–32. https://doi.org/10.1016/j.jacbts.2021.07.010.
  • White, Phillip J., Robert W. McGarrah, Mark A. Herman, James R. Bain, Svati H. Shah, and Christopher B. Newgard. “Insulin action, type 2 diabetes, and branched-chain amino acids: A two-way street.” Mol Metab 52 (October 2021): 101261. https://doi.org/10.1016/j.molmet.2021.101261.
  • Truby, Lauren K., Jessica A. Regan, Stephanie N. Giamberardino, Olga Ilkayeva, James Bain, Christopher B. Newgard, Christopher M. O’Connor, et al. “Circulating long chain acylcarnitines and outcomes in diabetic heart failure: an HF-ACTION clinical trial substudy.” Cardiovasc Diabetol 20, no. 1 (August 3, 2021): 161. https://doi.org/10.1186/s12933-021-01353-z.
  • Yoneshiro, Takeshi, Naoya Kataoka, Jacquelyn M. Walejko, Kenji Ikeda, Zachary Brown, Momoko Yoneshiro, Scott B. Crown, et al. “Metabolic flexibility via mitochondrial BCAA carrier SLC25A44 is required for optimal fever.” Elife 10 (May 4, 2021). https://doi.org/10.7554/eLife.66865.
  • Peters, Anthony E., Ambarish Pandey, Colby Ayers, Kara Wegermann, Robert W. McGarrah, Justin L. Grodin, Manal F. Abdelmalek, et al. “Association of liver fibrosis risk scores with clinical outcomes in patients with heart failure with preserved ejection fraction: findings from TOPCAT.” ESC Heart Fail 8, no. 2 (April 2021): 842–48. https://doi.org/10.1002/ehf2.13250.
  • Walejko, Jacquelyn M., Bridgette A. Christopher, Scott B. Crown, Guo-Fang Zhang, Adrian Pickar-Oliver, Takeshi Yoneshiro, Matthew W. Foster, et al. “Branched-chain α-ketoacids are preferentially reaminated and activate protein synthesis in the heart.” Nat Commun 12, no. 1 (March 15, 2021): 1680. https://doi.org/10.1038/s41467-021-21962-2.
  • Karady, Julia, Thomas Mayrhofer, Nandini Meyersohn, Daniel Bittner, Pedro V. Staziaki, Balint Szilveszter, Travis Hallett, et al. “SEDENTARY LIFESTYLE AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE RISK SCORE PREDICT INCIDENT MAJOR ADVERSE CARDIOVASCULAR EVENTS IN SUBJECTS WITH HEPATIC STEATOSIS.” In GASTROENTEROLOGY, 160:S790–91, 2021.
  • Ellison, Stephen, Jawan W. Abdulrahim, Lydia Coulter Kwee, Nathan A. Bihlmeyer, Neha Pagidipati, Robert McGarrah, James R. Bain, William E. Kraus, and Svati H. Shah. “Novel plasma biomarkers improve discrimination of metabolic health independent of weight.” Sci Rep 10, no. 1 (December 7, 2020): 21365. https://doi.org/10.1038/s41598-020-78478-w.
  • White, Phillip J., Amanda L. Lapworth, Robert W. McGarrah, Lydia Coulter Kwee, Scott B. Crown, Olga Ilkayeva, Jie An, et al. “Muscle-Liver Trafficking of BCAA-Derived Nitrogen Underlies Obesity-Related Glycine Depletion.” Cell Rep 33, no. 6 (November 10, 2020): 108375. https://doi.org/10.1016/j.celrep.2020.108375.
  • Abdulrahim, Jawan W., Lydia Coulter Kwee, Fawaz Alenezi, Albert Y. Sun, Aris Baras, Teminioluwa A. Ajayi, Ricardo Henao, et al. “Identification of Undetected Monogenic Cardiovascular Disorders.” J Am Coll Cardiol 76, no. 7 (August 18, 2020): 797–808. https://doi.org/10.1016/j.jacc.2020.06.037.
  • Shah, Nishant P., Neha J. Pajidipati, Robert W. McGarrah, Ann Marie Navar, Sreekanth Vemulapalli, Michael A. Blazing, Svati H. Shah, Adrian F. Hernandez, and Manesh R. Patel. “Lipoprotein (a): An Update on a Marker of Residual Risk and Associated Clinical Manifestations.” Am J Cardiol 126 (July 1, 2020): 94–102. https://doi.org/10.1016/j.amjcard.2020.03.043.
  • Zeitouni, Michel, Stephanie N. Giamberardino, Robert McGarrah, Neha Pagidipati, Geoffrey S. Ginsburg, Udo Hoffmann, Ann Marie Navar, Pamela Douglas, and Svati Shah. “A NOVEL INFLAMMATORY MARKER OF GLYCOSYLATED PROTEINS IS ASSOCIATED WITH CAD AND INCIDENT EVENTS AND DEMONSTRATES AGE EFFECTS IN THE PROMISE TRIAL.” In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 75:263–263. ELSEVIER SCIENCE INC, 2020.
  • McGarrah, Robert W., Guo-Fang Zhang, Bridgette A. Christopher, Yann Deleye, Jacquelyn M. Walejko, Stephani Page, Olga Ilkayeva, Phillip J. White, and Christopher B. Newgard. “Dietary branched-chain amino acid restriction alters fuel selection and reduces triglyceride stores in hearts of Zucker fatty rats.” Am J Physiol Endocrinol Metab 318, no. 2 (February 1, 2020): E216–23. https://doi.org/10.1152/ajpendo.00334.2019.
  • Truby, Lauren K., Jessica A. Regan, Maggie Nguyen, Stephani Giamberardino, Robert J. Mentz, Robert W. McGarrah, Yinggan Zheng, et al. “Meteorin-like Glial Cell Differentiation Regulator is a Novel Protein Biomarker of Cardiovascular Outcomes in Patients With Diabetes and Vascular Disease: A TECOS Substudy.” In CIRCULATION, Vol. 142, 2020.
  • Truby, Lauren K., Lydia Kwee, Jessica A. Regan, Dawn E. Bowles, Carmelo A. Milano, Elizabeth Grass, Michael R. Bristow, Robert W. McGarrah, Christopher L. Holley, and Svati H. Shah. “Proteomic Profiles of Diabetic Heart Failure Report on Myocardial Metabolism, Ventricular Hypertrophy, and Endothelial Dysfunction.” In CIRCULATION, Vol. 142, 2020.
  • McGarrah, R. W., M. Ferencik, S. N. Giamberardino, A. Coles, U. Hoffmann, G. S. Ginsburg, W. E. Kraus, P. S. Douglas, and S. H. Shah. “Lipoprotein subclasses associated with high-risk coronary atherosclerotic plaque: insights from the PROMISE clinical trial.” In EUROPEAN HEART JOURNAL, 40:51–51. OXFORD UNIV PRESS, 2019.
  • Page, Stephani, Lydia Kwee, William Kraus, Phillip White, Adam Devore, Robert Mentz, Michael Bristow, et al. “Integrated Omics Analysis of Diabetic Heart Failure in Human Myocardium.” In CIRCULATION RESEARCH, Vol. 125. LIPPINCOTT WILLIAMS & WILKINS, 2019.
  • Lerman, Joseph B., Stephanie N. Giamberardino, Steven E. McNulty, William E. Kraus, Christopher L. Holley, Adrian F. Hernandez, Svati H. Shah, and Robert W. McGarrah. “A Unique Acylcarnitine Profile is Independently Associated with Diabetic Heart Failure and Associates with Adverse Clinical Outcomes: Insights from the FIGHT Trial.” In CIRCULATION RESEARCH, Vol. 125. LIPPINCOTT WILLIAMS & WILKINS, 2019.
  • Yoneshiro, Takeshi, Qiang Wang, Kazuki Tajima, Mami Matsushita, Hiroko Maki, Kaori Igarashi, Zhipeng Dai, et al. “BCAA catabolism in brown fat controls energy homeostasis through SLC25A44.” Nature 572, no. 7771 (August 2019): 614–19. https://doi.org/10.1038/s41586-019-1503-x.
  • Yu, Bing, Claudia Flexeder, Robert W. McGarrah, Annah Wyss, Alanna C. Morrison, Kari E. North, Eric Boerwinkle, et al. “Metabolomics Identifies Novel Blood Biomarkers of Pulmonary Function and COPD in the General Population.” Metabolites 9, no. 4 (April 1, 2019). https://doi.org/10.3390/metabo9040061.
  • Kelly, Jacob P., Brian J. Andonian, Mahesh J. Patel, Zhen Huang, Linda K. Shaw, Robert W. McGarrah, Salvador Borges-Neto, Eric J. Velazquez, and William E. Kraus. “Trends in cardiorespiratory fitness: The evolution of exercise treadmill testing at a single Academic Medical Center from 1970 to 2012.” Am Heart J 210 (April 2019): 88–97. https://doi.org/10.1016/j.ahj.2019.01.001.
  • Hunter, Wynn G., Robert W. McGarrah, Jacob P. Kelly, Michel G. Khouri, Damian M. Craig, Carol Haynes, G Michael Felker, et al. “High-Density Lipoprotein Particle Subfractions in Heart Failure With Preserved or Reduced Ejection Fraction.” J Am Coll Cardiol 73, no. 2 (January 22, 2019): 177–86. https://doi.org/10.1016/j.jacc.2018.10.059.
  • Abdulrahim, Jawan W., Lydia C. Kwee, Fawaz Alenezi, Aris Baras, Teminioluwa Ajayi, Christopher L. Holley, Robert W. McGarrah, et al. “Whole Exome Sequencing in a Cardiovascular Cohort Identifies Previously Undiagnosed Monogenic Cardiovascular Diseases.” In CIRCULATION, Vol. 140, 2019.
  • McGuinn, Laura A., Alexandra Schneider, Robert W. McGarrah, Cavin Ward-Caviness, Lucas M. Neas, Qian Di, Joel Schwartz, et al. “Association of long-term PM2.5 exposure with traditional and novel lipid measures related to cardiovascular disease risk.” Environ Int 122 (January 2019): 193–200. https://doi.org/10.1016/j.envint.2018.11.001.
  • McGarrah, Robert W., and William E. Kraus. “Cardiac Rehabilitation: New Emphasis on Metabolic Disease.” In Contemporary Cardiology, 311–22. Springer International Publishing, 2019. https://doi.org/10.1007/978-3-319-97622-8_15.
  • Wang, Yingxue, Bridgette A. Christopher, Kirkland A. Wilson, Deborah Muoio, Robert W. McGarrah, Henri Brunengraber, and Guo-Fang Zhang. “Propionate-induced changes in cardiac metabolism, notably CoA trapping, are not altered by l-carnitine.” Am J Physiol Endocrinol Metab 315, no. 4 (October 1, 2018): E622–33. https://doi.org/10.1152/ajpendo.00081.2018.
  • WHITE, PHILLIP J., ROBERT W. MCGARRAH, PAUL A. GRIMSRUD, W. E. N. -. H. S. U. A. N. YANG, G. U. O. -. F. A. N. G. ZHANG, JONATHAN M. HALDEMAN, M. I. C. H. E. L. L. E. ARLOTTO, et al. “Integration of BCAA and Lipid Metabolism by the BCKDH Kinase and Phosphatase.” In Diabetes, Vol. 67. American Diabetes Association, 2018. https://doi.org/10.2337/db18-1874-p.
  • White, Phillip J., Robert W. McGarrah, Paul A. Grimsrud, Shih-Chia Tso, Wen-Hsuan Yang, Jonathan M. Haldeman, Thomas Grenier-Larouche, et al. “The BCKDH Kinase and Phosphatase Integrate BCAA and Lipid Metabolism via Regulation of ATP-Citrate Lyase.” Cell Metab 27, no. 6 (June 5, 2018): 1281-1293.e7. https://doi.org/10.1016/j.cmet.2018.04.015.
  • Duscha, Brian D., Lucy W. Piner, Mahesh P. Patel, Karen P. Craig, Morgan Brady, Robert W. McGarrah, Connie Chen, and William E. Kraus. “Effects of a 12-week mHealth program on peak VO2 and physical activity patterns after completing cardiac rehabilitation: A randomized controlled trial.” Am Heart J 199 (May 2018): 105–14. https://doi.org/10.1016/j.ahj.2018.02.001.
  • McGarrah, Robert W., Scott B. Crown, Guo-Fang Zhang, Svati H. Shah, and Christopher B. Newgard. “Cardiovascular Metabolomics.” Circ Res 122, no. 9 (April 27, 2018): 1238–58. https://doi.org/10.1161/CIRCRESAHA.117.311002.
  • Sarzynski, Mark A., Jonathan J. Ruiz-Ramie, Jacob L. Barber, Cris A. Slentz, John W. Apolzan, Robert W. McGarrah, Melissa N. Harris, et al. “Effects of Increasing Exercise Intensity and Dose on Multiple Measures of HDL (High-Density Lipoprotein) Function.” Arterioscler Thromb Vasc Biol 38, no. 4 (April 2018): 943–52. https://doi.org/10.1161/ATVBAHA.117.310307.
  • McGarrah, Robert W., and Svati H. Shah. “Integrative Omics: Harnessing the Proteome to Maximize the Potential of the Genome.” Circulation 137, no. 11 (March 13, 2018): 1173–75. https://doi.org/10.1161/CIRCULATIONAHA.117.032807.
  • McGarrah, Robert W. “Metabolic Anthropology: Selection Pressure Shapes Fatty Acid Metabolism in Greenlandic Inuit Populations.” Circ Cardiovasc Genet 10, no. 3 (June 2017). https://doi.org/10.1161/CIRCGENETICS.117.001802.
  • McGarrah, Robert W., Ann M. Navar, Stephanie Giamberardino, Adrian Coles, Lydia C. Kwee, Udo Hoffmann, Geoffrey S. Ginsburg, William E. Kraus, Pamela S. Douglas, and Svati H. Shah. “NMR Lipoprotein Profiling Identifies HDL Subclasses Associated With Obstructive CAD: Insights From the PROMISE Clinical Trial,” 136:A18001–A18001. American Heart Association, Inc., 2017.
  • McGarrah, Robert W., Jacob P. Kelly, Damian M. Craig, Carol Haynes, Ryan C. Jessee, Kim M. Huffman, William E. Kraus, and Svati H. Shah. “A Novel Protein Glycan-Derived Inflammation Biomarker Independently Predicts Cardiovascular Disease and Modifies the Association of HDL Subclasses with Mortality.” Clin Chem 63, no. 1 (January 2017): 288–96. https://doi.org/10.1373/clinchem.2016.261636.
  • McGarrah, Robert W., Cris A. Slentz, and William E. Kraus. “The Effect of Vigorous- Versus Moderate-Intensity Aerobic Exercise on Insulin Action.” Curr Cardiol Rep 18, no. 12 (December 2016): 117. https://doi.org/10.1007/s11886-016-0797-7.
  • Hunter, W., J. P. Kelly, R. W. McGarrah, M. G. Khouri, D. M. Craig, C. Haynes, O. Ilkayeva, et al. “Plasma amino acid concentrations are independently associated with adverse outcomes in heart failure and preserved ejection fraction: prognostic utility of amino acid profiles in HFpEF.” In European Heart Journal, 37:S1-P1671. Oxford University Press, 2016.
  • McGarrah, Robert W. “Refocusing the AIM on HDL in the metabolic syndrome.” Atherosclerosis 251 (August 2016): 531–33. https://doi.org/10.1016/j.atherosclerosis.2016.06.051.
  • McGarrah, Robert W., and Svati H. Shah. “Exomes, Proteins, and Cardiovascular Disease: Making Sense of the Signals.” Circ Cardiovasc Genet 9, no. 4 (August 2016): 318–19. https://doi.org/10.1161/CIRCGENETICS.116.001549.
  • Hunter, Wynn G., Jacob P. Kelly, Robert W. McGarrah, Michel G. Khouri, Damian Craig, Carol Haynes, Olga Ilkayeva, et al. “Metabolomic Profiling Identifies Novel Circulating Biomarkers of Mitochondrial Dysfunction Differentially Elevated in Heart Failure With Preserved Versus Reduced Ejection Fraction: Evidence for Shared Metabolic Impairments in Clinical Heart Failure.” J Am Heart Assoc 5, no. 8 (July 29, 2016). https://doi.org/10.1161/JAHA.115.003190.
  • Samad, Zainab, Amit N. Vora, Allison Dunning, Phillip J. Schulte, Linda K. Shaw, Fawaz Al-Enezi, Mads Ersboll, et al. “Aortic valve surgery and survival in patients with moderate or severe aortic stenosis and left ventricular dysfunction.” Eur Heart J 37, no. 28 (July 21, 2016): 2276–86. https://doi.org/10.1093/eurheartj/ehv701.
  • White, Phillip J., Amanda L. Lapworth, Jie An, Liping Wang, Robert W. McGarrah, Robert D. Stevens, Olga Ilkayeva, et al. “Branched-chain amino acid restriction in Zucker-fatty rats improves muscle insulin sensitivity by enhancing efficiency of fatty acid oxidation and acyl-glycine export.” Mol Metab 5, no. 7 (July 2016): 538–51. https://doi.org/10.1016/j.molmet.2016.04.006.
  • Hunter, Wynn G., Jacob P. Kelly, Robert W. McGarrah, William E. Kraus, and Svati H. Shah. “Metabolic Dysfunction in Heart Failure: Diagnostic, Prognostic, and Pathophysiologic Insights From Metabolomic Profiling.” Curr Heart Fail Rep 13, no. 3 (June 2016): 119–31. https://doi.org/10.1007/s11897-016-0289-5.
  • McGarrah, Robert W., Damian M. Craig, Carol Haynes, Z Elaine Dowdy, Svati H. Shah, and William E. Kraus. “High-density lipoprotein subclass measurements improve mortality risk prediction, discrimination and reclassification in a cardiac catheterization cohort.” Atherosclerosis 246 (March 2016): 229–35. https://doi.org/10.1016/j.atherosclerosis.2016.01.012.
  • Ahmad, Tariq, Jacob P. Kelly, Robert W. McGarrah, Anne S. Hellkamp, Mona Fiuzat, Jeffrey M. Testani, Teresa S. Wang, et al. “Prognostic Implications of Long-Chain Acylcarnitines in Heart Failure and Reversibility With Mechanical Circulatory Support.” J Am Coll Cardiol 67, no. 3 (January 26, 2016): 291–99. https://doi.org/10.1016/j.jacc.2015.10.079.
  • Hunter, W., R. W. McGarrah, J. P. Kelly, C. Haynes, E. J. Velazquez, W. E. Kraus, and S. H. Shah. “Circulating High-Density Lipoprotein Particle Profiles Are Independently Associated With Heart Failure With Preserved Ejection Fraction and Predict Adverse Clinical Outcomes.” In Circulation Journal, 134:A12679–A12679. The Japanese Circulation Society, 2016.
  • Kwee, L. C., W. Hunter, R. W. McGarrah, J. P. Kelly, D. M. Craig, P. Shipkova, M. Reily, et al. “Global Metabolomic Profiling in Heart Failure With Preserved Ejection Fraction Identifies Markers of Myocardial Dysfunction.” In Circulation Journal, 134:A17979–A17979. The Japanese Circulation Society, 2016.
  • Cooper, Lauren B., Jacob A. Doll, Jacob P. Kelly, Robert W. McGarrah, Tiffany C. Randolph, Joseph A. Sivak, Amit N. Vora, and Emily P. Zeitler. “A Company of Equals: Success Through Friendship in Fellowship.” J Am Coll Cardiol 66, no. 5 (August 4, 2015): 589–91. https://doi.org/10.1016/j.jacc.2015.06.016.
  • Kelly, J. P., W. Hunter, R. W. McGarrah, D. Craig, C. Haynes, E. J. Velazquez, G. M. Felker, et al. “Novel Protein Glycan Inflammatory Biomarkers Predict Adverse Events in Heart Failure with Preserved Ejection Fraction.” In Journal of Cardiac Failure, 21:S89–S89, 2015. https://doi.org/10.1016/j.cardfail.2015.06.266.
  • McGarrah, Robert W., Tariq Ahmad, Dwight D. Koeberl, and Chetan B. Patel. “The heart is just a muscle.” Circulation 131, no. 10 (March 10, 2015): 914–22. https://doi.org/10.1161/CIRCULATIONAHA.114.011647.
  • McGarrah, Robert, Damian Craig, Carol Haynes, Z Elaine Dowdy, Svati Shah, and William Kraus. “GLYCA, A NOVEL BIOMARKER OF SYSTEMIC INFLAMMATION, IMPROVES CARDIOVASCULAR RISK PREDICTION IN A HIGH-RISK CORONARY CATHETERIZATION COHORT.” In Journal of the American College of Cardiology, 65:A1606–A1606. Elsevier BV, 2015. https://doi.org/10.1016/s0735-1097(15)61606-0.
  • Kelly, J. P., W. Hunter, D. Craig, C. Haynes, R. McGarrah, E. Velazquez, M. Felker, et al. “Metabolomic Profiling Identifies Biomarkers Predicting Adverse Outcomes in Patients with Heart Failure with Preserved Ejection Fraction.” In Journal of the American College of Cardiology, 65:A772–A772, 2015. https://doi.org/10.1016/S0735-1097(15)60772-0.
  • Hunter, W., J. Kelly, D. Craig, C. Haynes, R. McGarrah, E. Velazquez, G. M. Felker, et al. “Metabolomic Profiling Identifies Biomarkers of Mitochondrial Function in Heart Failure with Preserved versus Reduced Ejection Fraction.” In Journal of the American College of Cardiology, 65:A774–A774, 2015. https://doi.org/10.1016/S0735-1097(15)60774-4.
  • McGarrah, Robert, Damian M. Craig, Carol Haynes, Elizabeth Hauser, Christopher B. Newgard, Simon G. Gregory, William Kraus, and Svati Shah. “OMICS PROFILING HIGHLIGHTS ENDOPLASMIC RETICULUM-ASSOCIATED DEGRADATION AND UBIQUITIN PROTEASOME PATHWAYS IN INSULIN RESISTANCE AND GLYCEMIC CONTROL.” Journal of the American College of Cardiology 63, no. 12 (April 2014): A1600–A1600. https://doi.org/10.1016/s0735-1097(14)61603-x.
  • McGarrah, Robert W., Damian M. Craig, Carol Haynes, Z Elaine Dowdy, Svati H. Shah, and William E. Kraus. “High-density Lipoprotein Particle Concentration Has a Stronger Inverse Association With Cardiovascular Events Than High-density Lipoprotein Cholesterol in a Coronary Catheterization Population.” In CIRCULATION, Vol. 128. LIPPINCOTT WILLIAMS & WILKINS, 2013.
  • Rottiers, Veerle, Susanna Obad, Andreas Petri, Robert McGarrah, Marie W. Lindholm, Joshua C. Black, Sumita Sinha, et al. “Pharmacological inhibition of a microRNA family in nonhuman primates by a seed-targeting 8-mer antimiR.” Sci Transl Med 5, no. 212 (November 20, 2013): 212ra162. https://doi.org/10.1126/scitranslmed.3006840.
  • McGarrah, Robert, Svati Shah, Elizabeth Hauser, Carol Haynes, Deborah Winegar, Ray Pourfarzib, and William Kraus. “NMR-BASED LIPOPROTEIN PARTICLE PROFILING IDENTIFIES NOVEL SIGNATURES FOR CARDIOVASCULAR DISEASE.” In Journal of the American College of Cardiology, 61:E1213–E1213. Elsevier BV, 2013. https://doi.org/10.1016/s0735-1097(13)61213-9.
  • Kakoki, Masao, Robert W. McGarrah, Hyung-Suk Kim, and Oliver Smithies. “Bradykinin B1 and B2 receptors both have protective roles in renal ischemia/reperfusion injury.” Proceedings of the National Academy of Sciences 104, no. 18 (May 2007): 7576–81. https://doi.org/10.1073/pnas.0701617104.
  • Hunter, W., J. P. Kelly, and R. W. McGarrah. “Plasma amino acid concentrations are independently associated with adverse outcomes in heart failure and preserved ejection fraction: prognostic utility of amino acid profiles in HFpEF,” n.d.
  • Kwee, L. C., W. Hunter, R. W. McGarrah, J. P. Kelly, D. M. Craig, P. Shipkova, M. Reily, et al. “Global Metabolomic Profiling in Heart Failure With Preserved Ejection Fraction Identifies Markers of Myocardial Dysfunction,” n.d.